OCR Seals Distribution Rights - Analyst Blog

By
A A A

Advanced Care Scripts (ACS), a part of Omnicare Inc. 's ( OCR ) Specialty Care Group, has been recently included in the limited distribution network for Lundbeck's Xenazine (tetrabenazine).

Xenazine is the only treatment for chorea which has been approved by the U.S. Food and Drug Administration (FDA). Chorea is a primary indication of Huntington's disease, as clinical studies have revealed that roughly 90% of those who suffer from chorea are affected by Huntington's disease.

Management at Omnicare's Specialty Care Group is enthused about its addition to the limited distribution network for the contemporary drug. The company is also the exclusive provider of Xenazine in the long-term care channel. The business model of the Specialty Care Group is best suited to dispense a specialty drug like Xenazine via its specialty pharmacy, ACS,  to the target population.

Revenues from the Specialty Care Group surged 25.7% year over year to $330.1 million in the second quarter. Omnicare is focused on exploiting new operating platforms to accelerate growth for the Specialty Care Group.

Omnicare is a market leading provider of long-term care pharmacy services and health care environment for individuals directly and indirectly, through subsidiaries across North America. It competes with PharMerica Corporation ( PMC ) and National Healthcare Corp . ( NHC ) in certain niche segments.  

Omnicare's business model ensures that it is well placed to sustain profitability in the long-run. Its performance in the most recent quarter negated external pricing pressure and reimbursement cuts.

Moreover, generics coming to the market in the next few quarters present a major opportunity due to the company's direct access to manufacturers and current greater exposure to the institutional pharmacy channel than in the past couple of years.

The stock currently retains a Zacks #1 Rank, which translates into a short-term Strong Buy rating.


 
NATL HEALTHCARE (NHC): Free Stock Analysis Report
 
OMNICARE INC (OCR): Free Stock Analysis Report
 
PHARMERICA CORP (PMC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: NHC , OCR , PMC

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Voya – Babies Retirement
Voya – Babies Retirement            

Stocks

Referenced

Most Active by Volume

28,614,868
  • $8.45 ▲ 6.56%
23,289,985
  • $104.99 ▲ 1.94%
21,718,756
  • $16.69 ▲ 1.77%
20,521,238
  • $33.579 ▼ 2.67%
13,539,306
  • $12.605 ▼ 1.75%
13,423,534
  • $97.94 ▲ 1.63%
11,430,079
  • $80.08 ▲ 2.18%
10,616,346
  • $58.97 ▼ 16.03%
As of 10/23/2014, 10:55 AM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com